Beginning in 1974, cancer research on the MIT campus was organized by the Center for Cancer Research (CCR), which held the distinction of a NCI designated Cancer Center since its inception. In 2008, the CCR was renamed the David H. Koch Institute for Integrative Cancer Research (Kl) at MIT in recognition of a major expansion of the MIT's commitment to inter-disciplinary cancer research as well as a significant donation by Mr. Koch. In launching the Kl, the outstanding tradition of cancer science represented by the MIT CCR has been joined by a new focus on cancer-relevant engineering. Kl Investigators, who are drawn from multiple departments in the MIT Schools of Science and Engineering, will study cancer in many ways, using highly collaborative and integrative approaches with a clearly defined mission to apply advanced science and new technologies in the fight against cancer. A state-of-the-art building to house the Kl is currently under construction to be completed in late 2010. The Kl building will house approximately 25 Center members at capacity. An additional 20 member of this Center have laboratories located in other MIT Departments. Due to expansion of the Kl faculty and expanded focus on inter-disciplinary cancer research, we have increased from three Programs to four and reorganized each Program. The Programs are: 1 Molecular Genetics and Immunology;2 Animal Models and Genetics;3 Cell and Systems Biology;4 Engineering Science and Technology. In addition, each Program will be overseen by co-leaders to draw on the strengths of our faculty in science and engineering. Respectively, Phillip Sharp and Dane Wittrup, Tyler Jacks and Angelika Amon, Richard Hynes and Michael Yaffe, and, Robert Langer and Sangeeta Bhatia lead the four Programs. Each program is organized around common interests of the members and overlapping long-range goals. There is extensive intra-programmatic interaction among the members of these programs and many examples of inter-programmatic interaction as well. Of the 43 members listed in this CCSG application, 24 will be located the Koch Institute building at opening. The others are located in the Koch Biology Building (5), the Whitehead Institute (7), the Division of Biological Engineering (2), the Broad Institute (2), the Department of Chemistry (2), and the Center for Environmental Health Sciences (1). The Koch Institute has been organized to apply a broad range of tools and systems in biological sciences, engineering and the physical sciences to advance our understanding of cancer development, progression and response to therapy. This research also holds great potential for new discoveries for improved cancer treatment, detection and monitoring.

Public Health Relevance

The Koch Institute has been organized to apply a broad range of tools and systems in biological sciences, engineering and the physical sciences to advance our understanding of cancer development, progression and response to therapy. This research also holds great potential for new discoveries for improved cancer treatment, detection and monitoring.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA014051-43
Application #
8680147
Study Section
Subcommittee G - Education (NCI)
Program Officer
Shafik, Hasnaa
Project Start
1997-06-17
Project End
2015-04-30
Budget Start
2014-05-01
Budget End
2015-04-30
Support Year
43
Fiscal Year
2014
Total Cost
$3,738,697
Indirect Cost
$1,474,619
Name
Massachusetts Institute of Technology
Department
Internal Medicine/Medicine
Type
Schools of Arts and Sciences
DUNS #
001425594
City
Cambridge
State
MA
Country
United States
Zip Code
02139
Tentori, Augusto M; Nagarajan, Maxwell B; Kim, Jae Jung et al. (2018) Quantitative and multiplex microRNA assays from unprocessed cells in isolated nanoliter well arrays. Lab Chip 18:2410-2424
Parisi, Tiziana; Balsamo, Michele; Gertler, Frank et al. (2018) The Rb tumor suppressor regulates epithelial cell migration and polarity. Mol Carcinog 57:1640-1650
Gam, Jeremy J; Babb, Jonathan; Weiss, Ron (2018) A mixed antagonistic/synergistic miRNA repression model enables accurate predictions of multi-input miRNA sensor activity. Nat Commun 9:2430
Chen, Huihui; Cho, Kin-Sang; Vu, T H Khanh et al. (2018) Commensal microflora-induced T cell responses mediate progressive neurodegeneration in glaucoma. Nat Commun 9:3209
Tam, Brooke E; Hao, Yining; Sikes, Hadley D (2018) An examination of critical parameters in hybridization-based epigenotyping using magnetic microparticles. Biotechnol Prog 34:1589-1595
Ramadi, Khalil B; Dagdeviren, Canan; Spencer, Kevin C et al. (2018) Focal, remote-controlled, chronic chemical modulation of brain microstructures. Proc Natl Acad Sci U S A 115:7254-7259
Knouse, Kristin A; Lopez, Kristina E; Bachofner, Marc et al. (2018) Chromosome Segregation Fidelity in Epithelia Requires Tissue Architecture. Cell 175:200-211.e13
Sabari, Benjamin R; Dall'Agnese, Alessandra; Boija, Ann et al. (2018) Coactivator condensation at super-enhancers links phase separation and gene control. Science 361:
Fiedler, Eleanor R C; Bhutkar, Arjun; Lawler, Emily et al. (2018) In vivo RNAi screening identifies Pafah1b3 as a target for combination therapy with TKIs in BCR-ABL1 + BCP-ALL. Blood Adv 2:1229-1242
Clancy-Thompson, Eleanor; Devlin, Christine A; Tyler, Paul M et al. (2018) Altered Binding of Tumor Antigenic Peptides to MHC Class I Affects CD8+ T Cell-Effector Responses. Cancer Immunol Res 6:1524-1536

Showing the most recent 10 out of 904 publications